Prescription drug · ANDA
Melphalan hydrochloride NDC 54288-109
Kit · BPI Labs LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 54288-109-02 | 5428801090254288010902 | 1 KIT in 1 CARTON (54288-109-02) * 10 mL in 1 VIAL, SINGLE-DOSE (54288-106-01) * 10 mL in 1 VIAL, SINGLE-USE (54288-107-01)Marketed from Jul 2, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Melphalan hydrochloride
- Generic name (nonproprietary)
- melphalan hydrochloride
- Dosage form
- Kit
- Labeler
- BPI Labs LLCNDC labeler code 54288
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209197
- Marketing start
- Listing expires
- Identifiers
- Product ID 54288-109_731e5310-a610-419d-bae0-89d4d2702731SPL ID 731e5310-a610-419d-bae0-89d4d2702731SPL set ID dab93975-0587-4f12-848c-9130bb02d036RxCUI 311487UPC 0354288109024
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N454288010902followed by a unit qualifier and the quantityPackage 54288-0109-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
Excerpt only. Read the full label for complete information.
About NDC 54288-109
- What is NDC 54288-109?
- 54288-109 is the product NDC for Melphalan hydrochloride kit, listed with the FDA by BPI Labs LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Melphalan hydrochloride.
- Who is the labeler?
- BPI Labs LLC, NDC labeler code 54288. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Melphalan hydrochloride?
- 12 other product NDCs are listed under this name. See all Melphalan hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Melphalan hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Melphalan hydrochloride | — | Kit | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-355 | 23155-0355-41 |
| Melphalan Hydrochloride | — | KitIntravenous | Arthur Group LLC | 84679-001 | 84679-0001-01 |
| Melphalan Hydrochloride | — | KitIntravenous | Dr.Reddy's Laboratories Inc | 75907-112 | 75907-0112-11 |
| Melphalan Hydrochloride | — | Kit | Camber Pharmaceuticals, Inc. | 31722-362 | 31722-0362-31 |
| Melphalan Hydrochloride | — | KitIntravenous | Sagent Pharmaceuticals | 25021-258 | 25021-0258-61 |
| Melphalan Hydrochloride | — | KitIntravenous | Qilu Pharmaceutical Co., Ltd. | 67184-0618 | 67184-0618-02 |
| Melphalan Hydrochloride | — | KitIntravenous | Avenacy Inc. | 83634-202 | 83634-0202-61 |
| Melphalan hydrochloride | — | KitIntravenous | Meitheal Pharmaceuticals Inc. | 71288-132 | 71288-0132-90 |
| Melphalan hydrochloride | — | Kit | Fosun Pharma USA Inc | 72266-128 | 72266-0128-01 |
| Melphalan hydrochloride | — | Kit | Gland Pharma Limited | 68083-259 | 68083-0259-01 |